Q: I have a 1% position in RHT that was purchased at a recent high { momentum ? }. I am down 15% and I am considering adding more or cutting my losses and moving on. The stock is in my TFSA where I expect reasonable growth over 3 years . Is doubling down at $2.00 a wise move ? Thank you.
Q: HI 5i, My TFSA account contains all this: CSU KXS PHO SIS, I'm looking may be for a new Stock. Considering COV or RHT, or any other (you think is better fit for me), of these two which one would you suggest for growth , some risk is ok.
I was wondering what your thoughts are on RHT given it's current price ( ~$2.22 as of today). Based on the most recent share count outstanding (81,871,000), this suggests an EV of about $180 MM for a company that is showing 6 month revenue of $1.1 MM. While I know that early stage companies are based on what the future holds, I also like to keep an eye on what EBITDA needs to be (in the future) to justify valuations. For instance, in the case of RHT, if one believes that within the next 12-24 months they can achieve EBITDA of ~ $12 MM, then this would suggest that today it is trading at a EV/EBITDA multiple of 15 based on future results. EBITDA of $12 MM in turn is achievable if they can hit ~ $20.5 MM in gross revenue with a 78% gross margin (as per most recent financials) and no increase in cash expenses of $4.0 MM annually, as 6 month financials suggest ~ $2.0 MM in cash expenses. In short, does your modelling of RHT suggest/indicate that this is a realistic expectation, and that within the 12-24 month time frame they can reach ~ $20 MM in gross revenue with no margin compression and no increase in cash G&A costs ?
Q: Hello 5i
I see you continue to be positive on RHT and recommend it at all near term prices.
With an effort to protect against downside movement in holdings owned, one of the technical rules I am working to utilize is to not purchase investments with declining stock prices.
What are your thoughts on buying RHT here ($2.23) and with the awareness of a price that appears to be undergoing a short term technical pullback. (potentially magnitude may be 1/3 of the rise)
Q: Comments on Conference call today.Why was it halted @ 10.32am et today.Did it provide Q results,if not,then why.Txs for u usual great services & vidws
Q: RHT and PHO are both small cap, growth and higher risk companies.
How would you compare their numbers and which one would you buy today
and why for a longer term hold?
Thank you always for your good advice.
Q: 1776 % on the year.
1336% on the 6 month
250% on the 3 month
92% in the 20 days that I have been following it since you recommended it.
So is this a crap shoot or a real company ? Have I missed it ? I have really bad memories of my Canarim / VSE days in the 1980s .
Q: Just an observation after following some frustrated posts the last few days. Members have the opportunity to add RHT today at what appears to be within $.04 of where you added to the portfolio. You guys definitely moved the market on it but this should be a lesson to subscribers to take your advice but be patient with it and wait for the right time to add to their own portfolio rather than rush to join the herd if there is an initial run up.
Q: Hi, RHT and VB were added to 5i Balanced and Growth portfolios, respectively, last week. Does it mean that the risk/growth profile of Versa Bank ( Growth) is higher when compared to Relique Health ( Balanced ) ? Any rationale, why this and not vice-versa.
Also, I could not find much information about Versa Bank in Q&A section. Could you please provide some more details/comments about this co. Thanks
Q: Hello 5i, just a comment. I have a note that some "locked in" shares in Reliq become come "unlocked" today Feb.22. That might be the reason for the slide in price.
Dave
Q: Hi, Now that RHT has been added to 5i portfolio, could you please provide an initial very brief summary on the company, including a possible 5i rating and growth expectations, specially there being no analyst coverage. Comments about the management will also be helpful. Share count seems to be large. What is the insiders and major institution holdings (separately) ? Considering that Patient Health Monitoring was touted by several high profile portfolio managers for a long time but at last, proved to be a huge disappointment to a large number of retail investors (including many of them being 5i subscribers), any relevant details will be most comforting. Thank You
PS: I know, you mentioned that there is no rush to buy/sell a stock based upon 5i portfolio changes. But, I did take a small position on Friday, but would love to have more insight/comfort before adding more. Tks